newsfilter
← Latest News
PR Newswire·

BioVaxys Further Expands Vaccines Intellectual Property Portfolio

VANCOUVER, BC, Sept. 28, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") announced today that in an action that further expands the value of their IP portfolio, the Company has broadened the p